Yüklüyor......
Interstitial lung disease points to consider for clinical trials in systemic sclerosis
Interstitial lung disease causes major morbidity and mortality in patients with systemic sclerosis (SSc-ILD). Large randomized clinical trials in SSc-ILD have provided important information regarding the feasibility, reliability and validity of outcome measures. Forced vital capacity percentage pred...
Kaydedildi:
| Yayımlandı: | Rheumatology (Oxford) |
|---|---|
| Asıl Yazarlar: | , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Oxford University Press
2017
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5850349/ https://ncbi.nlm.nih.gov/pubmed/28992174 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/rheumatology/kex203 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|